Cell Impact AB (publ)

Cell Impact AB (publ)

CI.ST
Cell Impact AB (publ)SE flagStockholm Stock Exchange
0.07
SEK
+0.00
- -
21.42MMarket Cap

Total Valuation

Cell Impact AB (publ) carries a market capitalization of 21.42M, placing it among publicly traded companies globally. Its enterprise value stands at 41.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap21.42M
Enterprise Value41.37M

Share Statistics

Cell Impact AB (publ) currently has 487.23M shares outstanding.

Shares Outstanding487.23M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 5.24, and the price-to-book ratio stands at -0.05.

PE RatioN/A
PS Ratio5.24
PB Ratio-0.05
P/TBV Ratio0.27
P/FCF Ratio-0.71
P/OCF Ratio-0.69

Enterprise Valuation

EV / Sales7.12
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Cell Impact AB (publ) maintains a current ratio of 3.06, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.17, indicating elevated leverage, while an interest coverage ratio of -41.83 demonstrates limited ability to service its debt obligations.

Current Ratio3.06
Quick Ratio0.19
Debt / Equity12.17
Debt / EBITDA-0.12
Interest Coverage-41.83

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-66.64
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.18

Taxes

Income Tax43,000.00
Effective Tax RateN/A

Stock Price Statistics

Cell Impact AB (publ)'s stock has declined approximately -72.45283% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.21.

Beta (5Y)N/A
52-Week Price Change-72.45283%
50-Day Moving Average0.15
200-Day Moving Average0.21
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Cell Impact AB (publ) generated 5.81M in revenue and converted that into -128.93M in net income, yielding earnings per share of -0.50. EBITDA reached -123.70M, while operating income came in at -123.70M.

Revenue5.81M
Gross Profit-2.48M
Operating Income-123.70M
Pretax Income-128.89M
Net Income-128.93M
EBITDA-123.70M
EBIT-123.70M
Earnings Per Share (EPS)-0.50

Balance Sheet

Cell Impact AB (publ) holds 3.95M in cash and equivalents against 14.87M in total debt, resulting in a net debt position of 1.41M. Total book value stands at -602.04M, with working capital of 42.01M providing operational flexibility.

Cash & Cash Equivalents3.95M
Total Debt14.87M
Net Debt1.41M
Equity (Book Value)-602.04M
Book Value Per Share-2.31
Working Capital42.01M

Cash Flow

Cell Impact AB (publ) produced -44.30M in operating cash flow over the past twelve months. After subtracting -1.46M in capital expenditures, free cash flow totaled -45.76M - equivalent to -0.18 per share.

Operating Cash Flow-44.30M
Capital Expenditures-1.46M
Free Cash Flow-45.76M
FCF Per Share-0.18

Margins

Cell Impact AB (publ) operates with a gross margin of -42.73, reflecting its pricing power and cost economics. The operating margin of -2,129.79 and net profit margin of -2,219.87 provide insight into operational efficiency.

Gross Margin-42.73
Operating Margin-2,129.79
Pretax Margin-2,219.11
Profit Margin-2,219.87
EBITDA Margin-2,129.79

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-130.51
FCF Yield-140.63

Stock Splits

Cell Impact AB (publ)'s most recent stock split took place on August 25, 2025 with a 10:1 split ratio.

Last Split Date8/25/2025
Split Ratio10:1

Scores

Cell Impact AB (publ) posts an Altman Z-Score of -8.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-8.44